Is FHTX a good investment?
As of 2025-04-18, the Fair Value of Foghorn Therapeutics Inc. (FHTX) is -7.79 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 3.80 USD, the upside of Foghorn Therapeutics Inc. is -304.95%. This means that FHTX is not a good investment.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -68.80 | -101.32 | -108.88 | -98.43 | -86.62 | -92.81 |
| YoY growth | -34.56% | -47.27% | -7.46% | 9.60% | 11.99% | -13.54% |
| Market Cap (mil) | 211.32 |
| P/E | |
| Forward P/E |
| EPS | -1.56 |
| Avg earnings growth rate | -13.54% |
| TTM earnings | -86.62 |